-Livemint.com Data from National Sample Survey Office’s (NSSO) 2011 round shows that domestic workers fare worse in comparison with others employed in the informal sector Mumbai: On Sunday, Prime Minister Narendra Modi broke down at a Facebook Inc. townhall recalling his mother’s toil as a domestic help. For decades, the poor condition of domestic workers has been a reality in India. Data from the National Sample Survey Office’s (NSSO) 2011 round shows that...

A day before the Prime Minister of India left for a two-nation tour to Ireland and the United States this September, the National Health Profile 2015 was released by the Minister of Health and Family Welfare Shri JP Nadda. The report, which has presented a dismal picture of the state of public health, shows that cases of cancer is expected to rise in India by almost 15 percent from 11.5...

-The Hindu Of the two crore pending cases, two-thirds are criminal At the rate at which cases were disposed by India’s district courts last month, India could get rid of all pending cases in ten years, an analysis of new official data shows. Six states, however – Bihar, Gujarat, Jharkhand, Maharashtra, West Bengal and Jammu & Kashmir – disposed fewer cases than were filed during the month, indicating that at this rate,...

-The Times of India India and her neighbors are going through a tortuous process of urbanization - slow, messy and partly hidden. This is seen in severe problems of livability and congestion, making cities unattractive for rural migrants. As a result, whatever benefits urban agglomerations could have offered in terms of economic advance are getting diluted. This is the dire analysis of a 200-page World Bank report on urbanization in South...

-The Times of India MUMBAI: Certain medicines are being aggressively marketed in India despite inadequate evidence of safety and efficacy, putting patients at risk, said reputed medical journal Lancet. Highlighting weak regulation and monitoring of the domestic drug industry, three recently-introduced medicines are being prescribed and sold though there is a lack of rigorous trials on crucial safety and efficacy parameters. The pharmaceutical industry in India should face the same stringent regulations...